. Mice p14 ARF is a putative tumor suppressor gene thought to deficient in p19 ARF are susceptible to a variety of spontaneous modify the levels of p53. CpG sites within the 5Ј-flanking and induced neoplasms (11, 12) . In addition, p14 ARF is freregion and exon 1β of p14 ARF are targets of aberrant quently deleted in human cancers; thus, the ARF locus is methylation and transcriptional silencing in human colorecconsidered a potential human tumor suppressor (13). p19 ARF tal cancer (CRC). Here we have developed methylationhas recently been ascribed a role in modifying the levels of specific polymerase chain reaction (MSPCR) methods to p53 by interacting with MDM2 and inhibiting MDM2-mediated detect methylation of CpG sites in p14 ARF in CRC cell lines p53 degradation via the ubiquitin/proteosome pathway (14). and primary CRC tumors, and correlated p14 ARF mRNA Wild-type p53 itself down-regulates p19 ARF expression, indicatexpression with methylation in CRC cell lines using competing a 'self-regulating feedback' loop between the two componitive quantitative reverse transcription-polymerase chain ents. Further, p19 ARF has not been shown to affect p53 levels reaction methods. Ten CRC cell lines were studied; three after DNA damage but is required for induction of p53 in (DLD-1, HCT15 and SW48) showed extensive methylation response to hyperproliferative signals such as c-Myc, E1A and and six (Colo320, SW480, HT29, Caco2, SW837 and WiDr) Ras (15-17). Our aim was to develop MSPCR methods to were unmethylated; the other cell line, LoVo, showed detect p14 ARF methylation in human tumor specimens. To partial methylation that affected exon 1β but not the maximize efficiency we explored multiplex MSPCR. During immediate upstream CpG sites. p14 ARF mRNA was the course of these experiments we encountered an anomalous expressed at extremely low levels in fully methylated cell PCR result with our multiplex MSPCR method in the LoVo lines and at 10 4 -to 10 5 -fold higher levels in unmethylated cell line that led to the discovery of a pattern of methylation cell lines. p14 ARF expression in the partially methylated characterized by 'partial' methylation within the untranslated
region (i.e. exon 2) but has a unique promoter and first exon (exon 1β) located~20 kb upstream of p16 INK4a (9, 10) . Mice p14 ARF is a putative tumor suppressor gene thought to deficient in p19 ARF are susceptible to a variety of spontaneous modify the levels of p53. CpG sites within the 5Ј-flanking and induced neoplasms (11, 12) . In addition, p14 ARF is freregion and exon 1β of p14 ARF are targets of aberrant quently deleted in human cancers; thus, the ARF locus is methylation and transcriptional silencing in human colorecconsidered a potential human tumor suppressor (13) . p19 ARF tal cancer (CRC). Here we have developed methylationhas recently been ascribed a role in modifying the levels of specific polymerase chain reaction (MSPCR) methods to p53 by interacting with MDM2 and inhibiting MDM2-mediated detect methylation of CpG sites in p14 ARF in CRC cell lines p53 degradation via the ubiquitin/proteosome pathway (14) . and primary CRC tumors, and correlated p14 ARF mRNA Wild-type p53 itself down-regulates p19 ARF expression, indicatexpression with methylation in CRC cell lines using competing a 'self-regulating feedback' loop between the two componitive quantitative reverse transcription-polymerase chain ents. Further, p19 ARF has not been shown to affect p53 levels reaction methods. Ten CRC cell lines were studied; three after DNA damage but is required for induction of p53 in (DLD-1, HCT15 and SW48) showed extensive methylation response to hyperproliferative signals such as c-Myc, E1A and and six (Colo320, SW480, HT29, Caco2, SW837 and WiDr)
Ras (15) (16) (17) . Our aim was to develop MSPCR methods to were unmethylated; the other cell line, LoVo, showed detect p14 ARF methylation in human tumor specimens. To partial methylation that affected exon 1β but not the maximize efficiency we explored multiplex MSPCR. During immediate upstream CpG sites. p14 ARF mRNA was the course of these experiments we encountered an anomalous expressed at extremely low levels in fully methylated cell PCR result with our multiplex MSPCR method in the LoVo lines and at 10 4 -to 10 5 -fold higher levels in unmethylated cell line that led to the discovery of a pattern of methylation cell lines. p14 ARF expression in the partially methylated characterized by 'partial' methylation within the untranslated
LoVo cell line was intermediate. Treatment of LoVo cells
region of exon 1β of p14 ARF . This partial methylation pattern with 2 µM 5-aza-2Ј-deoxycytidine for 72 h was associated was associated with reduced levels of p14 ARF mRNA and with marked (100-fold) induction of mRNA levels. Of represents the predominant pattern of p14 ARF methylation in 119 primary CRCs, 18% contained p14 ARF methylation, primary sporadic CRCs. although partial methylation was the most common pattern observed (in 67% of methylated tumors). After bisulfite treatments and methylation-specific amplificaimmediately frozen at -80°C. Non-tumorous colon tissue was tion, PCR products were gel purified (Qiagen) and ligated into also collected. Patients provided signed informed consent; all the PCR 2.1-TOPO plasmid vector using the TA cloning procedures were approved by the Hospital Clinic's institutional system (Invitrogen, Carlsbad, CA). Plasmid-transformed review board. Information was collected on patient characterEscherichia coli were cultured overnight and plasmid DNA was istics (age and gender) and tumor characteristics (stage at isolated (Qiagen). Purified plasmid DNA containing p14 ARF diagnosis, anatomical location and degree of differentiation).
sequence was sequenced in both directions using an ABI 373 MSPCR automated sequencer with dye primer chemistry and standard Methylated CpG sites within the 5Ј region of the p14 ARF gene M13 primers. were detected using MSPCR methods. For all assays, 1.0 µg Quantitative competitive PCR and p14 ARF expression of purified DNA was diluted in 36 µl H 2 O, to which was Expression of p14 ARF mRNA in CRC cell lines was measured added 4 µl of 3.0 M NaOH and the DNA denatured at 37°C
by quantitative competitive PCR as previously described (18) . for 15 min. The samples were then treated with 416 µl of In this method, target cDNA is amplified in the presence of a 3.6 M sodium bisulfite solution (pH 5.0) and 24 µl of 10 mM known concentration of a competitor sequence that has the hydroquinone. Both bisulfite and hydroquinone solutions were same primer binding sites and the same amplification efficiency prepared fresh for each analysis. Samples were incubated at as the target sequence. By serial dilution of the competitor, 55°C for 16 h; 100 µl of mineral oil was layered on top of the equivalence point (i.e. the point at which the ratio of target the solution to prevent evaporation. After incubation, the to competitor is 1:1) is determined. At the equivalence point, solution was cooled to -80°C for 10 min, after which the the amount of target cDNA can be quantified. Equal amounts unfrozen mineral oil was removed without disturbing the of total cDNA were added to each competitive PCR reaction bisulfite-DNA solution.
by normalizing cDNA with the concentration of HPRT cDNA; Bisulfite-modified DNA was purified with the Wizard DNA HPRT cDNA levels were estimated in each sample by competitClean-Up System and Vacuum Manifold (Promega, Madison, ive PCR as described (19) . PCR conditions were identical to WI) according to the manufacturer's instructions. DNA was those for MSPCR except in this instance 5% DMSO was not eluted with a total volume of 30 µl TE buffer (pH 7.8). The added. The p14 ARF competitor amplicon was constructed to final step of the cytosine→uracil conversion reaction was contain primer-binding sites that span exons 1β and 2 of the achieved by treatment with alkali (NaOH; final concentration p14 ARF cDNA, and to contain an 80 bp insert to make the 0.3 M) at 37°C for 15 min followed by neutralization with competitor and target amplicons distinguishable by agarose ammonium acetate (pH 7.0; final concentration 3.0 M) and gel electrophoresis. The 80 bp fragment was inserted at the ethanol precipitation. Human peripheral blood lymphocyte unique XmaI restriction site within p14 ARF exon 2. The number DNA treated with methylase SssI (New England BioLabs, of copies of p14 ARF cDNA present at the equivalence point Beverly, MA) was used as a positive control.
was calculated using the competitor DNA concentration and For each cell line and tumor specimen, both monoplex and dilution factor at the equivalence point, and the molecular multiplex PCR amplification of bisulfite-treated DNA was weight of the competitor. Visual inspection followed by UV carried out with primers (BRL) specific for methylated densitometry was used to carry out the serial dilutions and to (M-primer) and unmethylated (U-primer) CpG sites within measure equivalence of PCR bands. For 5-aza-2Ј-deoxythe p14 ARF promoter. Previous studies with p16 INK4a showed cytidine (AZA) treatments, cells were passaged and, 24 h later, complete concordance of multiplex and monoplex results. A treated with freshly prepared 2 µM AZA for 72 h; they were region including~150 bp upstream and downstream of the then harvested for RNA isolation. p14 ARF transcription initiation site was chosen for assay development. For p16 INK4a and hMLH1, primers were used as previously described (3,6).
Results The PCR mixture contained GeneAmp PCR buffer (PerkinMonoplex and multiplex MSPCR Elmer Corp., Foster City, CA), 1.5 mM MgCl 2 , dimethylsulfoxide (DMSO; 5% final concentration), 200 µM of each deoxynuIn our initial experiments, we designed two sets of methylationsensitive primers (M-primers and U-primers) to amplify CpGcleotide triphosphate), 0.4 µM of each primer, 50 ng modified DNA templates and 2.5 U of AmpliTaq with TaqStart antibody rich regions that are 5Ј flanking to exon 1β and within the initial portion of exon 1β ( Figure 1 ). The primers were designed (Clontech, Palo Alto, CA) in a total volume of 50 µl. The PCR reaction was repeated for 35 cycles on a GeneAmp so that the unmethylated product would share a common 5Ј location but the 3Ј U-primer would bind downstream of the 9600 thermal cycler (Perkin-Elmer Corp.) under the following conditions: preheat at 94°C for 2 min, 94°C for 30 s, 65°C 3Ј M-primer (i.e. primers A/D and B/C) ( Figure 1 ). This combination produces methylated and unmethylated PCR prodfor 10 s, 72°C for 30 s and a final extension at 72°C for 10 min. Aliquots (15 µl) of PCR products were loaded on to ucts of different sizes in multiplex reactions containing both M-and U-primers. We compared monoplex and multiplex 2.5% agarose gels stained with ethidium bromide and visualized under UV light.
amplifications using bisulfite-treated DNA isolated from nor- Table I . CRC cell lines. Figure 2a shows the results of monoplex Primers A and E in Figure 1 were used to amplify the region. (M or U) and multiplex (M and U) reactions using primer CpG positions are indicated relative to the transcription start pairs A/D (U-primers) and B/C (M-primers). For each cell site. Nine independent clones were sequenced; CpG sites in line except LoVo, a single band was detected in multiplex or the 5Ј-flanking region of p14 ARF were unmethylated but sites monoplex reactions; in SW480, SW837, HT29, WiDr, Colo320 ϩ32 and ϩ35 were extensively methylated. These latter sites and Caco2 the band was amplified only with U-primers, and lie within the methylated primer for the multiplex reaction and in HCT15, DLD-1, SW48 it was amplified only with occur within the untranslated region of exon 1β. These sites M-primers. In multiplex reactions LoVo produced a methylated correspond to CpG sites 6 and 7 in Figure 1 . The results product, but not in monoplex PCR reactions with M-primers confirm the MSPCR data indicating that the anomalous multionly. As shown in Figure 2a , row D, monoplex PCR with the plex product arose by the U-primer annealing upstream and U-and M-primer pair amplified a product in LoVo but not in the M-primer annealing downstream. Also consistent with this any other cell line. Also shown in Figure 2b is a sensitivity interpretation was the fact that the reverse combination of analysis indicating that methylation within the region can be primers [i.e. 5Ј M-primer (B) and 3Ј U-primer (D)] never detected when the methylated template is present at Ͼ3% of produced a PCR product in any cell line. Extensive methylation total template. The most striking result of these experiments of all 15 CpG sites in the region was confirmed by sequencing is the discordant results when LoVo cells were examined by in SW48 and DLD-1 cells and in the methylase-treated positive MSPCR in the monoplex versus multiplex format. The target control, whereas no CpG site was methylated in Colo320 cells sequence was amplified poorly from LoVo cells with either (data not shown). The partial pattern of methylation was also monoplex M-or U-primers but a very robust methylation band found in another cell line, HCT116. Because the sequencing was produced when both sets of primers were used. Our results primers were designed to be sensitive to the methylation status with monoplex PCR using a 5Ј U-primer and 3Ј M-primer of individual CpG sites, it should be noted that these sequencing (primers A/C; Figure 2a , row D) are consistent with the studies and those described in primary tumors do not give an formation of a hybrid product formed in the multiplex reaction.
unbiased picture of the distribution of CpG sites in this region. This explanation would require that the sequence chosen for Instead they were carried out to confirm the interpretation of multiplex PCR amplification would span a boundary region the multiplex result and provide evidence for the existence of that was unmethylated at one end and methylated at the other.
the two patterns of methylation (i.e. partial and extensive). Bisulfite sequencing p14 ARF mRNA expression The expression of p14 ARF was estimated for each cell line and We next amplified the putative boundary region with primers downstream of the previous M-primers (i.e. using primer the relative concentrations of p14 ARF cDNA are shown in Table I . Bisulfite sequencing of cloned PCR products from the LoVo cell line Clone CpG position 1/-59 2/-54 3/-37 4/-32 5/ϩ6 6/ϩ32 7/ϩ35 8/ϩ40 9/ϩ47 10/ϩ53 11/ϩ65 12/ϩ68 13/ϩ84 14/ϩ102 15/ϩ108
Primers A and E in Figure 1 were used to amplify the region. CpG positions are indicated relative to the transcription start site and percentage methylation based on 9 independent clones. Note that positions ϩ32 and ϩ35 lie within the methylated primer for the multiplex reaction and occur within the untranslated region of exon 1β. These sites correspond to CpG sites 6 and 7 in Figure 1 .and, not determined. Figure 3a . Expression was normalized to the cell plex, monoplex with 5Ј U-primer and 3Ј M-primer specific for line with the lowest level of expression (i.e. DLD-1), which the partial methylation, and monoplex with 5Ј M-primer and was assigned an arbitrary value of 1 unit of p14 ARF cDNA.
3Ј U-primer (Figure 4) . No PCR amplification was detected Methylated cell lines had very low levels of p14 ARF expression in any primary tumor using the 5Ј M-primer and 3Ј U-primer (1-230 relative units; mean, 79), whereas unmethylated cell combination. Similarly, this combination of primers failed to lines expressed an average of 1760-fold higher levels amplify product in all CRC cell lines. Twenty-one tumors (i.e. mean ϭ 139 000). LoVo cells expressed intermediate were methylated in multiplex reactions; however, monoplex levels of p14 ARF , with 33-fold higher levels than in methylated reactions showed that only seven of these were extensively cell lines and 54-fold lower levels than in unmethylated methylated. Most methylated primary tumors were found to cell lines.
contain the partial pattern of methylation (Table III) . In To confirm that the intermediate and low mRNA levels of addition, methylation was associated with increased age, female p14 ARF in LoVo cells were associated with CpG methylation, gender, proximal location and poor differentiation. In Figure  LoVo cells were cultured for 72 h in the presence of AZA.
5 we present a graphical representation of these clinicopatholp14 ARF levels were induced 100-fold (26 ϫ 10 4 relative units) ogical correlations; we calculated the Kendall correlation by AZA in LoVo cells (Figure 3b ). The methylated cell line coefficient to test for trends in p14 ARF methylation (i.e. DLD-1 also showed a 10 000-fold increase in p14 ARF transcripts unmethylated, partial methylation or extensive methylation) after AZA treatment but still expressed much lower levels of with each of the patient variables. The Kendall correlation is p14 ARF than LoVo or unmethylated cell lines (1 ϫ 10 4 units).
a non-parametric approach used here to test for trends in Expression of p14 ARF in the unmethylated cell line SW837 methylation with selected patient characteristics. A significant was unaffected by the AZA treatment (10.5 ϫ 10 4 units, or a correlation implies that the numerical value of a variable 15% decrease).
in patients with partially methylated tumors is intermediate
Prevalence of p14 ARF methylation in primary tumors
between the values for patients with unmethylated and extensively methylated tumors. As is evident from Figure 5 , a A total of 119 primary cancers were assayed using five different MSPCR protocols: monoplex for extensive methylation, multisignificant Kendall correlation was observed for the proportion unmethylated products yielded unmethylated CpG sites. In non-tumorous colon, p14 ARF methylation was never detected. We also found the partial pattern of methylation in a second CRC cell line, HCT116. Thus, LoVo is not the only cell line exhibiting this pattern of p14 ARF methylation. Among the 119 primary tumors there was a significant correlation of p14 ARF and p16 INK4a methylation (χ 2 ϭ16.8; P Ͻ 0.001 for any p14 ARF methylation); the association between p16 INK4a methylation and partial p14 ARF methylation showed extensive methylation throughout the 5Ј flanking region in DLD-1; however, an~10 000-fold lower dilution factor was required to achieve the equivalence point (row A), indicating a marked reactivation of near exon 1β, whereas LoVo cells, which display 33-fold higher p14 ARF in DLD-1. levels of mRNA expression, contain a partially methylated CpG island that spans the exon 1β transcription site. Our sequencing results indicate that CpG sites immediately upstream of the of female patients, increased age and proximal location but not for stage or differentiation. Hence, these data suggest an transcription start site are unmethylated in partially methylated DNA from LoVo cells. MSPCR analysis using a 5Ј U-primer intermediate phenotype (age, gender and anatomical location) associated with the partial pattern of methylation. It is also and a 3Ј M-primer readily detected this unique pattern. We never observed the opposite pattern (i.e. 5Ј-methylated and 3Ј clear from the data that extensive but not partial methylation is associated with poor differentiation. This is reflected in the unmethylated) in any cell line or primary tumor. It is of interest that the two methylated CpG sites positioned within the 3Ј statistically significant association of extensive methylation and differentiation in Table III but a non-significant Kendall M-primer are in the untranslated region of exon 1β; these sites were previously reported to be located within a potential correlation in Figure 5 . Several tumors demonstrating methylation and one unmethylated tumor were sequenced using the binding site for members of the E2F family of transcription factors. In addition, the p14 ARF promoter was found to be A and E sequencing primers. The partial methylation by MSPCR was confirmed by sequencing and was similar to the highly responsive to E2F1 expression (20). Our results showing a 100-fold induction of p14 ARF mRNA levels in LoVo cells pattern observed in LoVo cells. All CRC tumor specimens contained unmethylated products, which probably represent after AZA treatment are consistent with this site being a functioning promoter element in p14 ARF . This hypothesis will non-tumorous elements in the surgical specimen. Sequencing require further study, however, because CpG sites downstream sporadic CRCs. About 18% of CRCs showed methylation using multiplex MSPCR. Of the methylated tumors, however, of the translation start signal were also heavily methylated. Generally, CpG methylation within coding regions of exons is the majority of tumors (14/21; 67%) showed the partial methylation pattern observed in the LoVo cell line. Interesthought to be permissive in transcriptional regulation (21) . In addition, a previous study using restriction digestion and tingly, we observed significant trends between the three patterns of methylation (unmethylated, partially methylated, extensively Southern blots indicated that further upstream sites in the 5Ј-flanking region of LoVo cells were also methylated. methylated) and female gender, proximal tumor location and older age. These data indicate that partial methylation, which It is now thought that p16 INK4a and p14 ARF are regulated independently. Our finding that all cell lines contained p16 INK4a showed intermediate in vitro mRNA expression in cell lines, may be associated with an intermediate clinical phenotype methylation, but only four of the 10 were methylated at p14 ARF is consistent with this idea. Our data showing discordance in vivo. In contrast, the degree of tumor differentiation was inversely associated with extensive but not partial methylation. between p16 INK4a and p14 ARF methylation in primary tumors also confirms the independence of methylation events within This latter result suggests that the more complete silencing of p14 ARF expression by extensive methylation compared with the respective promoters of these two genes. Our MSPCR results were also consistent with the previously reported partial methylation may be required to promote the poorly differentiated tumor growth pattern. methylated and unmethylated alleles within hMLH1 in HT29; the score methylation pattern was detected in WiDr, which is
The associations of p14 ARF methylation with female gender and proximal tumor location are similar to our previous studies derived from HT29 (22) . SW48 also showed methylation of the hMLH1. Among the unmethylated cell lines, we observed of p16 INK4a in this series of patients (8) . The clustering of both of these methylation events within CRCs arising in the proximal a 45-fold variation in p14 ARF expression levels. The significance of this variation is unknown. The unmethylated cell lines colon is consistent with the hypothesis that there exists a hypermethylation phenotype for a subset of CRCs. Our data, showing the lowest p14ARF expression were Colo320, SW480 and HT29. Other researchers have shown that c-myc is amplihowever, also show that the methylation status of 50% of CRCs were discordant at the two loci. Thus, our findings fied 35-, 4-and 1.8-fold in Colo320, SW480 and HT29, respectively (23). No other cell lines in our series are known emphasize that even among CRC exhibiting hypermethylation, different genetic pathways can be targeted in individual cases. to contain c-myc amplification. Expression of p14 ARF may be reduced in cell lines containing c-myc amplification through Further research is needed to elucidate the mechanisms that give rise to the specific constellation of genes affected by the action of trans-acting factors. For example, down-regulation of p14 ARF by the transcriptional repressor bmi-1 has recently aberrant methylation. The significance of these differences in methylation patterns with respect to the etiology of CRC, or been shown to be involved in cell immortalization by cmyc (24). Further investigation of the variations in p14 ARF their potential to improve diagnosis or prognosis, also remains to be determined. expression we have observed may provide clues concerning methylation-independent mechanisms modifying p14 ARF It is evident that extensive methylation of p14 ARF is not common in sporadic CRC. Similarly, p14 ARF is seldom extensexpression.
To examine whether the two patterns of methylation found ively methylated in bladder cancer (25). However, the partial methylation pattern we found associated with relatively low in established CRC cell lines were detectable in primary human tumors, we applied MSPCR methods to a series of 119 primary levels of p14 ARF in the LoVo cell line appears relatively example, a multiplex MSPCR to identify methylated tumors, followed by monoplex PCR reactions on methylated tumors References using the 5Ј U-/3Ј M-primer or 5Ј M-/3Ј M-primer combinations
